1. Home
  2. VTSI vs MAIA Comparison

VTSI vs MAIA Comparison

Compare VTSI & MAIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo VirTra Inc.

VTSI

VirTra Inc.

N/A

Current Price

$2.86

Market Cap

51.0M

ML Signal

N/A

Logo MAIA Biotechnology Inc.

MAIA

MAIA Biotechnology Inc.

HOLD

Current Price

$1.22

Market Cap

79.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VTSI
MAIA
Founded
1993
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Miscellaneous manufacturing industries
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
51.0M
79.0M
IPO Year
1999
2022

Fundamental Metrics

Financial Performance
Metric
VTSI
MAIA
Price
$2.86
$1.22
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
★ $5.00
N/A
AVG Volume (30 Days)
18.9K
★ 555.8K
Earning Date
05-11-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 33.33
EPS
★ N/A
N/A
Revenue
★ $185,971.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$27.30
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.86
$0.87
52 Week High
$6.29
$3.19

Technical Indicators

Market Signals
Indicator
VTSI
MAIA
Relative Strength Index (RSI) 40.46 36.46
Support Level N/A $1.13
Resistance Level $3.59 $1.48
Average True Range (ATR) 0.08 0.08
MACD -0.00 -0.01
Stochastic Oscillator 12.50 2.00

Price Performance

Historical Comparison
VTSI
MAIA

About VTSI VirTra Inc.

VirTra Inc is a U.S.-based company that is engaged in the sale and development of judgmental use-of-force training simulators and firearms training simulators for law enforcement, military, and commercial uses. It sells simulators and related products across the globe through a direct sales force and international distribution partners. The services provided by the company include installation, training, limited warranties, service agreements, and related support. The company operates in six segments, which include Simulators and Accessories, Extended Service, Customized software and Custom content, Installation and Training, Design and Prototyping, and Subscription Training Equipment Partnership. The majority of its revenue is generated from the Simulators and Accessories segment.

About MAIA MAIA Biotechnology Inc.

MAIA Biotechnology Inc is a clinical-stage biopharmaceutical company engaged in the discovery, development, and commercialization of targeted immunotherapies for cancer, with an initial focus on non-small cell lung cancer (NSCLC), which represents the majority of lung cancer cases. Its asset, ateganosine (THIO, also known as 6-thio-dG or 6-thio-deoxyguanosine), is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. The treatment approach involves administering THIO followed by the immune checkpoint inhibitor Libtayo (cemiplimab), which is manufactured and commercialized by Regeneron.

Share on Social Networks: